Conformational Analysis of Selectins
选择素的构象分析
基本信息
- 批准号:6886585
- 负责人:
- 金额:$ 4.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-01 至 2008-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Selectins are important molecules in mediating cell-cell contacts between leukocytes and endothelial cells, by binding to carbohydrate ligands on opposing cells. These contacts lead to leukocyte rolling, an early step in the inflammatory response. Inhibiting these interactions provides a possible approach to treating a number of disorders including arthritis, psoriasis, and metastasis. The selectins undergo large conformational changes during the process of rolling that alter their affinity for carbohydrates. Here it is proposed that a crystal structure of the high affinity conformation of P-selectin (created by Uyen Phan in the Springer lab) will be solved with and without bound ligand. In parallel, crystallization of L-selectin will be an immediate goal, as there are no structures for L-selectin, and there are substrate specificity differences among the selectins. P-selectin locked in a low affinity conformation will be constructed by the addition of disulfide bonds, and crystallized, with and without bound carbohydrate. Flow chamber assays will be used to assess the binding of this low affinity conformation to various substrates. This work will give insight into the mechanism of rolling, and the important structural features of the carbohydrate binding interface, the likely target for inhibitors.
描述(由申请人提供):选择素是介导白细胞和内皮细胞之间细胞-细胞接触的重要分子,通过与相对细胞上的碳水化合物配体结合。这些接触导致白细胞滚动,这是炎症反应的早期步骤。抑制这些相互作用提供了一种可能的方法来治疗许多疾病,包括关节炎,银屑病和转移。选择素在滚动过程中经历大的构象变化,从而改变其对碳水化合物的亲和力。 在这里,提出了P-选择素的高亲和力构象的晶体结构(由Uyen Phan在Springer实验室创建)将在有和没有结合配体的情况下得到解决。 平行地,L-选择素的结晶将是直接目标,因为没有L-选择素的结构,并且在选择素之间存在底物特异性差异。锁定在低亲和力构象的P-选择素将通过添加二硫键来构建,并在有或没有结合的碳水化合物的情况下结晶。将使用流动室测定来评估这种低亲和力构象与各种底物的结合。这项工作将深入了解滚动的机制,以及碳水化合物结合界面的重要结构特征,这可能是抑制剂的目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TRAVIS T WALDRON其他文献
TRAVIS T WALDRON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TRAVIS T WALDRON', 18)}}的其他基金
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 4.21万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 4.21万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 4.21万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 4.21万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 4.21万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 4.21万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 4.21万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 4.21万 - 项目类别:
Studentship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 4.21万 - 项目类别:














{{item.name}}会员




